These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 24742779)

  • 21. Medication safety in a psychiatric hospital.
    Rothschild JM; Mann K; Keohane CA; Williams DH; Foskett C; Rosen SL; Flaherty L; Chu JA; Bates DW
    Gen Hosp Psychiatry; 2007; 29(2):156-62. PubMed ID: 17336665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient safety incident reports related to traditional Japanese Kampo medicines: medication errors and adverse drug events in a university hospital for a ten-year period.
    Shimada Y; Fujimoto M; Nogami T; Watari H; Kitahara H; Misawa H; Kimbara Y
    BMC Complement Altern Med; 2017 Dec; 17(1):547. PubMed ID: 29268743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and preventability of adverse drug events in hospitalized adults.
    Bates DW; Leape LL; Petrycki S
    J Gen Intern Med; 1993 Jun; 8(6):289-94. PubMed ID: 8320571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse drug events and medication errors: detection and classification methods.
    Morimoto T; Gandhi TK; Seger AC; Hsieh TC; Bates DW
    Qual Saf Health Care; 2004 Aug; 13(4):306-14. PubMed ID: 15289635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist surveillance of adverse drug events.
    Forster AJ; Halil RB; Tierney MG
    Am J Health Syst Pharm; 2004 Jul; 61(14):1466-72. PubMed ID: 15332694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of preventable adverse drug events: a review of the literature.
    von Laue NC; Schwappach DL; Koeck CM
    Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
    Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
    PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review.
    Alghamdi AA; Keers RN; Sutherland A; Ashcroft DM
    Drug Saf; 2019 Dec; 42(12):1423-1436. PubMed ID: 31410745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.
    Kuklik N; Stausberg J; Amiri M; Jöckel KH
    BMC Health Serv Res; 2019 Aug; 19(1):555. PubMed ID: 31395053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventable adverse drug events and their causes and contributing factors: the analysis of register data.
    Jylhä V; Saranto K; Bates DW
    Int J Qual Health Care; 2011 Apr; 23(2):187-97. PubMed ID: 21242162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug events caused by serious medication administration errors.
    Kale A; Keohane CA; Maviglia S; Gandhi TK; Poon EG
    BMJ Qual Saf; 2012 Nov; 21(11):933-8. PubMed ID: 22791691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and impact of adverse drug events in pediatric inpatients.
    Holdsworth MT; Fichtl RE; Behta M; Raisch DW; Mendez-Rico E; Adams A; Greifer M; Bostwick S; Greenwald BM
    Arch Pediatr Adolesc Med; 2003 Jan; 157(1):60-5. PubMed ID: 12517196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with reported preventable adverse drug events: a retrospective, case-control study.
    Beckett RD; Sheehan AH; Reddan JG
    Ann Pharmacother; 2012 May; 46(5):634-41. PubMed ID: 22510670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High rates of adverse drug events in a highly computerized hospital.
    Nebeker JR; Hoffman JM; Weir CR; Bennett CL; Hurdle JF
    Arch Intern Med; 2005 May; 165(10):1111-6. PubMed ID: 15911723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia.
    Dedefo MG; Mitike AH; Angamo MT
    BMC Pediatr; 2016 Jul; 16():81. PubMed ID: 27387547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.